This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

TCR2 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TCRR?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	632,476	1.61%
VC/PE Firms	4,158,964	10.6%
Hedge Funds	7,765,782	19.8%
Institutions	10,256,870	26.1%
General Public	16,447,653	41.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 55.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.2%	Tang Capital Management, LLC	4,394,800	US$6.5m	29.3%	0.95%
10.6%	MPM Asset Management, L.L.C.	4,158,964	US$6.2m	2.67%	3.21%
8.59%	BioImpact Capital LLC	3,370,982	US$5.0m	0%	1.34%
3.74%	The Vanguard Group, Inc.	1,468,802	US$2.2m	2.62%	no data
2.59%	Newtyn Management, LLC	1,015,920	US$1.5m	-5.5%	0.28%
2.07%	Acadian Asset Management LLC	812,459	US$1.2m	-7.13%	no data
2.01%	BlackRock, Inc.	789,911	US$1.2m	-0.12%	no data
1.92%	Baker Bros. Advisors LP	753,064	US$1.1m	0%	0.01%
1.91%	Artal Group S.A.	750,000	US$1.1m	0%	0.06%
1.68%	Redmile Group, LLC	658,336	US$974.3k	-9.99%	0.04%
1.44%	Long Focus Capital Management LLC	566,270	US$838.1k	0%	0.15%
1.33%	J.P. Morgan Asset Management, Inc.	523,167	US$774.3k	0%	no data
1.13%	Renaissance Technologies LLC	444,800	US$658.3k	-35.8%	no data
1.03%	Garry Menzel	404,330	US$598.4k	0%	no data
0.98%	Citigroup Inc.,Banking and Securities Investments	383,486	US$567.6k	-19%	no data
0.8%	Geode Capital Management, LLC	315,377	US$466.8k	0%	no data
0.46%	Bridgeway Capital Management, LLC	181,810	US$269.1k	0%	0.01%
0.44%	Dimensional Fund Advisors LP	171,214	US$253.4k	-18.5%	no data
0.39%	Morgan Stanley, Investment Banking and Brokerage Investments	155,059	US$229.5k	237%	no data
0.35%	State Street Global Advisors, Inc.	137,219	US$203.1k	25.5%	no data
0.31%	FMR LLC	120,633	US$178.5k	5.95%	no data
0.28%	Two Sigma Advisers, LP	111,000	US$164.3k	-55.5%	no data
0.28%	Alfonso Cardama	109,459	US$162.0k	0%	no data
0.24%	Northern Trust Global Investments	93,933	US$139.0k	8.6%	no data
0.19%	Victory Capital Management Inc.	74,297	US$110.0k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/06/03 16:15
End of Day Share Price	2023/05/31 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TCR2 Therapeutics Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Clarence Powell	BMO Capital Markets Equity Research
Guyn Kim	BMO Capital Markets Equity Research
Charles Butler	D. Boral Capital LLC.